Skip to main content
NSCLC Management of RET Mutations

NSCLC Management of RET Mutations

Dr. Aggarwal Discusses Management of "Rare" Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

Dr. Aggarwal Discusses Management of "Rare" Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

Scroll to Continue

Recommended Articles

shutterstock_2087020123
Survivorship

Cancer’s Glamour Girl

Diagnosed with CML at 23 Erin Ruddy shares her journey.

By CancerConnect5 hours ago
shutterstock_2069391023
Survivorship

Jonna's Body, Please Hold

Actress, playwright, and three-time cancer survivor Jonna Tamases celebrates life from center stage.

By CancerConnect5 hours ago
274864752_633879297819598_1001345989349798990_n
Treatment & Care

Neulasta Treatment of Neutropenia Improves Treatment

Understand the role of Neulasta treatment of Neutropenia to prevent infection and improve chemotherapy treatment.

By CancerConnectMay 18, 2022

You May Like

NSCLCAggarwal1620c
MD

NSCLC Management of ALK Mutations

Advances in the Management of "Rare" Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

By CancerConnectMay 10, 2022
NSCLCAggarwal1620c
MD

NSCLC NTRK Case Base Discussion Series

Advances in the Management of “Rare” Oncogenic Drivers in NSCLC- An Interactive Case Based Discussion

By CancerConnectMay 1, 2022
Saab1620c
MD

Hepatocellular Cancer – An Interactive Case Based Discussion

Advances in the Management of Hepatocellular Cancer – A Case Based Discussion

By CancerConnectMay 11, 2022
Saab Colorectal
MD

Rego Case

Advances in the Management of Advanced Colorectal Cancer – A Case Based Discussion

By CancerConnectMay 2, 2022
NSCLCAggarwal1620c
MD

NSCLC molecular testing

NSCLC molecular testing

By CancerConnectMay 2, 2022
Image placeholder title
Treatment & Care

Managing Locally Advanced NSCLC in the Elderly

Managing Locally Advanced NSCLC in the Elderly

By CancerConnectMar 20, 2007
Strickler Colorectal Cancer Case Base Discussion Series
MD

The “Circulate” Clinical Trial - ctDNA Dynamics and Clinical Outcomes in Colon Cancer

Dr John Stricker discusses what the recent data from "Circulate" tells us about integrating MRD assays into clinical practice?

By CancerConnectMay 10, 2022
Image placeholder title
Lung Cancer Treatment

FDA Approves Tafinlar and Mekinist for Treatment of V600 Mutated NSCLC

FDA grants regular approval to dabrafenib and trametinib combination for metastatic NSCLC with BRAF V600E mutation.

By CancerConnectMar 20, 2019
Image placeholder title
Myelodysplastic Syndrome

Updates in the Management of Myelodysplastic Syndromes

Updates in the Management of Myelodysplastic Syndromes

By CancerConnectJun 6, 2018